Oaks; Edwin V.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Oaks; Edwin V..The latest application filed is for "artificial invaplex formulated with deacylated lipopolysaccharide".

Company Profile

2.8.7

Oaks; Edwin V. - Gambrills MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Artificial invaplex formulated with deacylated lipopolysaccharide Grant 10,881,684 - Kaminski , et al. January 5, 2	2021-01-05
Artificial Invaplex Formulated with Deacylated Lipopolysaccharide App 20190099442 - Kaminski; Robert W. ; et al.	2019-04-04
Use of Shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo Grant 8,110,354 - Oaks , et al. February 7, 2	2012-02-07
Artificial invaplex Grant 7,780,966 - Oaks , et al. August 24, 2	2010-08-24
Use Of Shigella Invaplex To Transport Functional Proteins And Transcriptionally Active Nucleic Acids Across Mammalian Cell Membranes In Vitro And In Vivo App 20100119543 - OAKS; Edwin V. ; et al.	2010-05-13
Use of Shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo Grant 7,632,659 - Oaks , et al. December 15, 2	2009-12-15
Artificial invaplex App 20080241196 - Oaks; Edwin V. ; et al.	2008-10-02
Method For The Production Of Purified Invasin Protein And Use Thereof App 20070202124 - Picking; William D. ; et al.	2007-08-30
Heterologous protection induced by immunization with invaplex vaccine Grant 7,258,863 - Oaks , et al. August 21, 2	2007-08-21
Use of Shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo App 20050215474 - Oaks, Edwin V. ; et al.	2005-09-29
Invaplex from gram negative bacteria, method of purification and methods of use App 20050013822 - Oaks, Edwin V. ; et al.	2005-01-20
Invaplex from gram negative bacteria, method of purification and methods of use Grant 6,680,374 - Oaks , et al. January 20, 2	2004-01-20
Heterologous protection induced by immunization with invaplex vaccine App 20020197276 - Oaks, Edwin V. ; et al.	2002-12-26
Use of purified invaplex from gram negative bacteria as a vaccine Grant 6,277,379 - Oaks , et al. August 21, 2	2001-08-21
Invaplex from gram negative bacteria, method of purification and methods of use Grant 6,245,892 - Oaks , et al. June 12, 2	2001-06-12

Company Registrations

NCAGE Code	779K6	OAKS, EDWIN V!DBA PATUXENT RESEARCH AND CONSULTING!GROUP
CAGE Code	779K6	OAKS, EDWIN V PATUXENT RESEARCH AND CONSULTING GROUP
S.A.M. Registration	779K6 [79460120]	OAKS, EDWIN V PATUXENT RESEARCH AND CONSULTING GROUP
DUNS	079460120	Oaks, Edwin V

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.